Mi Young Bahng

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Namyi Gu, Min Kyu Park, Tae‐Eun Kim et al. · Drug Design Development and Therapy · 2014 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Study

Yukyung Kim, Mijeong Son, Dong Hwan Lee et al. · Clinical Therapeutics · 2013 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase‐4 inhibitor, evogliptin ( <scp>DA</scp> ‐1229)

Jaeseong Oh, Andrew HyoungJin Kim, SeungHwan Lee et al. · Diabetes Obesity and Metabolism · 2016 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects

Dongseong Shin, SeungHwan Lee, SoJeong Yi et al. · Drug Design Development and Therapy · 2017 · 10 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +13